Dr. Brewer also received the Heinrich Wieland Prize from the Federal Republic of Germany; the Public Health Service Commendation, Meritorious Service, and Distinguished Service Medals from the NIH; the George Lyman Duff Memorial Commendation Award Lecture; and the Robert I. Levy Award. Dr. Brewer has published more than 450 original manuscripts and 75 reviews and book chapters on the subjects of genetic dyslipoproteinemias, lipoprotein metabolism, and atherosclerosis. He has served on the boards of several prestigious journals and is currently on the editorial board of the Journal of Biological Chemistry.
James de Lemos, M.D., is the director of the Coronary Care Unit at Parkland Memorial Hospital and the director of the Cardiology Fellowship at the University of Texas Southwestern Medical School in Dallas, Texas. He is an associate professor of medicine and holds the J. Fred Schoelkopf Endowed Chair in Cardiology. He is an active investigator in the Donald W. Reynolds Cardiovascular Research Center at University of Texas Southwestern, and remains closely affiliated with the Thrombolysis in Myocardial Ischemia research group. His primary research interest is risk assessment and management of acute and chronic coronary artery disease. His other research interests include electrocardiography as a means of assessing the coronary microcirculation after thrombolysis or percutaneous coronary intervention, and the use of novel biomarkers for prognostic assessment among patients with coronary artery disease. He has worked extensively with novel biomarkers such as B-type natriuretic peptide, Monocyte Chemoattractant protein-1, and soluble CD40 ligand. He was recently the lead author of the Z phase of the A to Z trial, an international trial investigating different cholesterol-lowering strategies in patients with acute coronary syndromes. He graduated from Harvard Medical School and completed an Internal Medicine Residency at the University of Texas Southwestern Medical Center, where he also served as chief medical resident. He completed a Fellowship in Cardiovascular Medicine at Brigham and Women’s Hospital, and served on the faculty of Brigham and Women’s Hospital and Harvard Medical School before moving to University of Texas Southwestern Medical School. He has served on multiple committees of the AHA and ACC and is on the editorial board of the American Journal of Cardiology and the American Heart Journal. He has authored or coauthored over 150 manuscripts or book chapters and won several teaching awards.
David Dilts, Ph.D., M.B.A., is director of Clinical Research for the Knight Cancer Institute and professor of Healthcare Management at the Oregon Health & Science University. Currently, he is on leave as a joint professor of Management and Engineering Management in the Owen Graduate